Evidence map›Paper›PMID 34837923›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

Evaluation the Presence of SERPINA5 (Exon 3) and FTO rs9939609 Polymorphisms in Papillary Thyroid Cancer Patients.

Seyed Mohammad Moshtaghioun, Nasim Fazel-Yazdi, Mohammad Mandegari, Ahmad Shirinzadeh-Dastgiri, Mohammad Vakili, Habib Fazel-Yazdi

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Cytotoxicity of curcumin against CD44Avicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Seyed Mohammad MoshtaghiounDepartment of Biology, Faculty of Science, Yazd University, Yazd, Iran.
Nasim Fazel-YazdiDepartment of Biology, Faculty of Science, Yazd University, Yazd, Iran.
Mohammad MandegariDepartment of Otolaryngology, Head and Neck Surgery, Otorhinolaryngology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Ahmad Shirinzadeh-DastgiriDepartment of Surgery, School of Medicine, Shohadaye Hafte-e-tie hospital, Iran University of Medical Sciences, Tehran, Iran.
Mohammad VakiliDepartment of Surgery, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Habib Fazel-YazdiYazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Yazd University · IRArdabil University of Medical Sciences · IRDiabetes Research CenterShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA few researches evaluated the association of polymorphisms at SERPINA5 and fat mass and obesity-associated protein (FTO) genes with papillary thyroid cancer (PTC) globally. Here, we examined the presence of genetic variations within coding exon 3 of SERPINA5 gene and FTO rs9939609 polymorphism in Iranian PTC patients.

methodsA total of 122 patients (42 cases for SERPINA5 and 80 cases for FTO gene) and 120 healthy subjects (40 subjects or SERPINA5 and 80 subjects for FTO gene) were recruited. The genetic variation within coding exon 3 of SERPINA5 gene was evaluated by reaction-single-strand conformation polymorphism (PCR-SSCP) and FTO rs9939609 polymorphism was evaluated by RFLP-PCR assay.

resultsThe PCR-SSCP technique detected two rs6115G>A and rs6112T>C genetic variations within coding exon 3 of SERPINA5 gene and approved also by direct sequencing. For rs6112T>C polymorphism seven patients was heterozygous and for rs6115G>A seven PTC patients were heterozygous and two patients were homozygous.

conclusionThis study indicated that SERPINA5 rs6115G>A and rs6112T>C polymorphisms might be a novel susceptibility locus for PTC in Iranian patients. However, our findings do not support an association between FTO rs9939609 polymorphism and PTC risk.

Indexed as

Alpha-Ketoglutarate-Dependent Dioxygenase FTOCase-Control StudiesExonsFemaleHumansIranMalePolymerase Chain ReactionPolymorphism, Single-Stranded ConformationalProtein C InhibitorThyroid Cancer, PapillaryThyroid NeoplasmsAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanProtein C InhibitorSERPINA5 protein, humanFTOPapillary thyroid cancerPCR-SSCPSERPINA5Variation

Identifiers

PMID34837923
PMCPMC9068165
OpenAlexW3216823720

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.